Literature DB >> 22817333

Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia.

M P Colella, E V De Paula, N Conran, J A Machado-Neto, J M Annicchino-Bizzacchi, F F Costa, S T O Saad, F Traina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22817333     DOI： 10.1111/j.1538-7836.2012.04861.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  21 in total

Review 1.  Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.

Authors:  Dachuan Zhang; Chunliang Xu; Deepa Manwani; Paul S Frenette
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 2.  Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.

Authors:  Rakhi P Naik; Michael B Streiff; Sophie Lanzkron
Journal:  J Thromb Thrombolysis       Date:  2013-04       Impact factor: 2.300

3.  Elevated hypercoagulability markers in hemoglobin SC disease.

Authors:  Marina P Colella; Erich V de Paula; João A Machado-Neto; Nicola Conran; Joyce M Annichino-Bizzacchi; Fernando F Costa; Sara T Olalla Saad; Fabiola Traina
Journal:  Haematologica       Date:  2015-01-16       Impact factor: 9.941

4.  Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.

Authors:  Camille Faes; Anton Ilich; Amandine Sotiaux; Erica M Sparkenbaugh; Michael W Henderson; Laura Buczek; Joan D Beckman; Patrick Ellsworth; Denis F Noubouossie; Lantarima Bhoopat; Mark Piegore; Céline Renoux; Wolfgang Bergmeier; Yara Park; Kenneth I Ataga; Brian Cooley; Alisa S Wolberg; Nigel S Key; Rafal Pawlinski
Journal:  Blood       Date:  2019-04-05       Impact factor: 22.113

Review 5.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

Review 6.  How I diagnose and treat venous thromboembolism in sickle cell disease.

Authors:  Arun S Shet; Ted Wun
Journal:  Blood       Date:  2018-05-15       Impact factor: 22.113

7.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

Review 8.  Chronic Pulmonary Complications of Sickle Cell Disease.

Authors:  Alem Mehari; Elizabeth S Klings
Journal:  Chest       Date:  2016-01-13       Impact factor: 9.410

9.  Coagulation activation in sickle cell trait: an exploratory study.

Authors:  Chirag Amin; Soheir Adam; Micah J Mooberry; Abdullah Kutlar; Ferdane Kutlar; Denise Esserman; Julia E Brittain; Kenneth I Ataga; Jen-Yea Chang; Alisa S Wolberg; Nigel S Key
Journal:  Br J Haematol       Date:  2015-09-07       Impact factor: 6.998

10.  Role of innate immunity-triggered pathways in the pathogenesis of Sickle Cell Disease: a meta-analysis of gene expression studies.

Authors:  Bidossessi Wilfried Hounkpe; Maiara Marx Luz Fiusa; Marina Pereira Colella; Loredana Nilkenes Gomes da Costa; Rafaela de Oliveira Benatti; Sara T Olalla Saad; Fernando Ferreira Costa; Magnun Nueldo Nunes dos Santos; Erich Vinicius De Paula
Journal:  Sci Rep       Date:  2015-12-09       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.